Virginia Cancer Institute is a clinical research site located in Mechanicsville, Virginia, United States 23116-1844.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Virginia Cancer Institute has participated in 4 clinical trials.
Therapeutic areas: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Castration-Resistant Prostate Cancer, Pancreatic Ductal Carcinoma.
Sponsors: Pfizer, Halozyme Therapeutics.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Virginia Cancer Institute has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Cancer Institute has 4 clinical trials on record. Their work covers Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Castration-Resistant Prostate Cancer, Pancreatic Ductal Carcinoma.
Virginia Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.